Efficacy of antiplatelets in deep venous thrombosis

0
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Pharmacists in 2023: roles and remuneration

0
Better remuneration and career support are key to the future of pharmacists’ roles. The pharmacy profession provides a much broader range of health services...

Consultant pharmacist excellence awarded

0
Two pharmacists were honoured at PSA’s Consultant Pharmacist Conference (CPC26), held from 29–31 May 2026 on the Gold Coast.

Pharmacists in 2023 – unlocking the future of pharmacy

0
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...

Bushfire crisis brings out the best in pharmacists

It has been a tough start to 2020 for many Australians. The bushfire crisis has engulfed Australia, affecting virtually all states and territories.

Supporting patients to quit vaping: an important role for pharmacists

0
With vaping rates rising and regulatory changes reshaping access, pharmacists play an increasingly important role.